Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Am J Gastroenterol ; 112(5): 716-721, 2017 05.
Artigo em Inglês | MEDLINE | ID: mdl-27958287

RESUMO

OBJECTIVES: Current international guidelines for ocular radiation exposure suggest a threshold of 20 millisieverts (mSv)/year. Although endoscopists wear lead aprons, use of protective eye wear is optional. This study was conducted to analyze the lens radiation exposure during endoscopic retrograde cholangiopancreatography (ERCP) for endoscopists to determine the time of fluoroscopy needed to warrant using lens protection during ERCP. METHODS: ERCP patients were prospectively enrolled. Indications, interventions, fluoroscopy time, dose, and attending ± fellow involvement were recorded. Radiation exposure was collected from body dosimeters and dosimeters placed between the eyes. Cumulative radiation doses were obtained at study completion and averaged over the total fluoroscopy time to determine the mSv/hour exposure. RESULTS: A total of 187 cases were included. Attendings and fellows wore lens dosimeters in 178 and 126 cases, respectively, and body dosimeters in 174 and 128 cases, respectively. Attendings and fellows wore lens dosimeters throughout 15.89 and 11.24 h of fluoroscopy, respectively. The cumulative radiation dose absorbed per lens dosimeters was 5.35 mSv for attendings and 2.55 mSv for fellows. The projected lens absorption by the body dosimeters was 19.03 mSv for attendings and 5.21 mSv for fellows. The hourly fluoroscopy lens exposure was 0.34 mSv/hour for attendings and 0.23 mSv/hour for fellows. CONCLUSIONS: The amount of fluoroscopy hours needed to reach the currently suggested lens threshold limit (20 mSv/year) was 59.41 h for attendings and 88.17 h for fellows. Radioprotective eye wear should be worn by physicians with yearly fluoroscopy times in similarly structured practices that meet or exceed these thresholds.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica , Fluoroscopia , Gastroenterologia , Cristalino , Exposição Ocupacional , Doses de Radiação , Idoso , Dispositivos de Proteção dos Olhos , Bolsas de Estudo , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Exposição Ocupacional/prevenção & controle , Estudos Prospectivos , Monitoramento de Radiação , Níveis Máximos Permitidos , Fatores de Tempo
2.
Surg Laparosc Endosc Percutan Tech ; 29(1): 22-25, 2019 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-30520816

RESUMO

Radiation exposure during endoscopic retrograde cholangiopancreatography is known, however, data in relation to radiation usage is unclear. We evaluate radiation exposure using fluoroscopy dose (FD) and time (FT). A prospective analysis of 197 patients undergoing endoscopic retrograde cholangiopancreatography was completed. Univariate and multivariate analyses were performed to determine characteristics associated with higher FD and FT. The mean FT was 307 seconds; the mean FD was 16.5 centigray. On univariate and multivariate analysis, indication of common bile duct stricture and pancreatic stricture, interventions including dilation and the use of plastic stents placement, procedures that were moderately or very difficult, and procedures that used magnification and high-resolution images were associated with higher FD± and longer FT. Indications of common bile duct stricture and pancreatic stricture as well as interventions of dilation, plastic stents placement, and procedures that are moderately or very difficult, involve high-resolution image leading to a higher radiation exposure. Special care should be considered in these settings.


Assuntos
Colangiopancreatografia Retrógrada Endoscópica/efeitos adversos , Colestase/cirurgia , Fluoroscopia/efeitos adversos , Pancreatopatias/cirurgia , Ductos Pancreáticos/cirurgia , Colangiopancreatografia Retrógrada Endoscópica/métodos , Constrição Patológica/cirurgia , Feminino , Fluoroscopia/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Doses de Radiação , Fatores de Tempo
3.
Pediatr Neurol ; 36(6): 361-5, 2007 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-17560496

RESUMO

Recent reports implicating elevated cytokines in the central nervous system in a small number of patients studied with autism have reported clinical regression. These studies have not focused on tumor necrosis factor-alpha as a possible marker for inflammatory damage. A series of 10 children with autism had clinical evaluation of their serum and spinal fluid for inflammatory changes and possible metabolic disease as part of their neurological evaluation. Elevation of cerebrospinal fluid levels of tumor necrosis factor-alpha was significantly higher (mean = 104.10 pg/mL) than concurrent serum levels (mean = 2.78 pg/mL) in all of the patients studied. The ratio of the cerebrospinal fluid levels to serum levels averaged 53.7:1. This ratio is significantly higher than the elevations reported for other pathological states for which cerebrospinal fluid and serum tumor necrosis factor-alpha levels have been simultaneously measured. This observation may offer a unique insight into central nervous system inflammatory mechanisms that may contribute to the onset of autism and may serve as a potential clinical marker. More controlled study of this potentially important observation may prove valuable.


Assuntos
Transtorno Autístico/líquido cefalorraquidiano , Transtorno Autístico/imunologia , Encefalite/líquido cefalorraquidiano , Encefalite/imunologia , Fator de Necrose Tumoral alfa/líquido cefalorraquidiano , Transtorno Autístico/diagnóstico , Biomarcadores/líquido cefalorraquidiano , Sistema Nervoso Central/imunologia , Criança , Pré-Escolar , Diagnóstico Precoce , Encefalite/diagnóstico , Feminino , Humanos , Lactente , Masculino , Fator de Necrose Tumoral alfa/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA